ChemPartner is proud to spotlight our Collagen-induced Arthritis (CIA) model, a well-established pre-clinical tool for studying Rheumatoid Arthritis (RA) disease biology and evaluating novel therapeutic strategies. The CIA model recapitulates key hallmarks of human RA, making it a valuable platform for translating promising science into meaningful therapies.
If you’re working in immunology, autoimmune drug development, or musculoskeletal research, we would welcome the opportunity to connect and share insights.
Request a copy of our latest arthritis technical spotlight to learn more about:
- A background of the disease and current research areas
- Our recent case study in Type-II Collagen-induced Arthritis (CIA) in rats
- Our recent case study in Type-II Collagen-induced Arthritis (CIA) in mice
- Histopathology results, scoring, and insights
See how our Collagen-induced Rheumatoid Arthritis Model can accelerate your research and support better decisions.
